Overview

Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
A polysomnography study to evaluate the effect, safety and tolerability of oral administration of almorexant (ACT 078573) in adult subjects with primary insomnia.
Phase:
Phase 3
Details
Lead Sponsor:
Midnight Pharma, LLC
Treatments:
Zolpidem